Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 11/02/2025 7:48:26 PM
Board Marks: 394
Posts Today: 5
Board Views Today: 25682
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
MGK_2
07/02/2025 7:20:10 PM
CCR5 is not an immune check point, but
(15)
john1234
07/02/2025 6:59:45 PM
Well in that place if Leronlimab Kills
(1)
john1234
07/02/2025 6:48:11 PM
Just making sure
Evil Rabbit
07/02/2025 6:46:30 PM
Immune checkpoint inhibitor.
(1)
john1234
07/02/2025 6:29:58 PM
Im going to ask what are you all
chazzledazzle
07/02/2025 6:12:13 PM
Thanks for stating more clearly and
My69z
07/02/2025 4:09:26 PM
How much for exclusive ICI @ all
My69z
07/02/2025 3:03:16 PM
When do you, the ICI owner step-in with
(5)
My69z
07/02/2025 2:45:10 PM
Exclusive Right to test your ICI in
(3)
Riztheinvestor
07/02/2025 2:40:29 PM
Thanks bro! No need the FBI is already
(4)
Evil Rabbit
07/02/2025 2:37:26 PM
Excellent work, Riz. See if you can get
(4)
john1234
07/02/2025 2:34:48 PM
News Article July 1, 2025 Leronlimab
(1)
john1234
07/02/2025 2:28:41 PM
News Article May 16, 2025 Leronlimab
(5)
Riztheinvestor
07/02/2025 1:41:39 PM
Its LIVE. Thank you to those who
(17)
Ramjet
07/02/2025 1:23:39 PM
I understand your frustration and share
(7)
SamaGong
07/02/2025 1:23:14 PM
House, yes, I think you would be
(6)
misiu143
07/02/2025 1:03:54 PM
exactly , thank you.
Plotinus
07/02/2025 1:01:50 PM
Max reply to Ken on LinkedIn: Ken
(7)
misiu143
07/02/2025 12:34:10 PM
It was public reply , I believe. Anyone
(2)
misiu143
07/02/2025 12:31:48 PM
I don't know how to post here from
(1)
john1234
07/02/2025 11:50:56 AM
Dose this help on the matter VANCOUVER,
(4)
Evil Rabbit
07/02/2025 11:33:20 AM
Paging Ken Chowder I dont use
(1)
My69z
07/02/2025 11:30:12 AM
Could u post Max full comment by chance
HouseofCards
07/02/2025 11:14:35 AM
Correct me if I'm wrong, but if the
(1)
hoops
07/02/2025 11:00:19 AM
"So many things going on, I can't keep
(2)
My69z
07/02/2025 10:51:49 AM
July 11th is the last IRB meeting
(1)
brentie
07/02/2025 10:50:35 AM
"Third, we have finalized the protocol
(7)
Mr3Putt
07/02/2025 10:38:36 AM
IIRC, It's the Cornell trial, if it
(2)
MJS719
07/02/2025 10:24:14 AM
I noticed on the website that we did or
(1)
dfwl28
07/02/2025 9:51:11 AM
Ohm: "... Bring in a PD-L1 or PD-1
(2)
My69z
07/02/2025 9:43:44 AM
Thx SamaGong!...makes sense when you
(2)
Boatbuilder
07/02/2025 9:02:55 AM
The Morningstar mention is significant.
(2)
SamaGong
07/02/2025 8:37:15 AM
Yeah, adding ICI treatment into the mix
(3)
Plotinus
07/02/2025 8:32:29 AM
A better way of understanding protocol
(16)
Riztheinvestor
07/02/2025 8:11:36 AM
Morally negligent welp theyve
(1)
My69z
07/02/2025 7:18:22 AM
Some studies suggest that modulating
(6)
brentie
07/02/2025 7:14:48 AM
We're getting some coverage...
(24)
My69z
07/02/2025 2:14:40 AM
SK said in the 2022 video we hired a
(18)
HouseofCards
07/02/2025 1:33:23 AM
All this appears to say is that they
(2)
grow
07/02/2025 1:32:16 AM
Thank you for your insights
(1)
chazzledazzle
07/02/2025 1:22:37 AM
PD-L1 is just the perfume needed to get
(1)
chazzledazzle
07/02/2025 1:20:01 AM
This is exactly what I said but in my
(1)
ohm20
07/02/2025 1:12:34 AM
The question I think is what does he
(17)
chazzledazzle
07/02/2025 1:07:49 AM
That is correct. Expect a lag in any
(1)
ohm20
07/02/2025 12:52:05 AM
Heres the study overview. As well as
(8)
ohm20
07/02/2025 12:43:53 AM
OK , in this PR , but do you see
(24)
ohm20
07/02/2025 12:31:46 AM
PD-L1 (programmed death ligand one) is
(18)
grow
07/02/2025 12:14:41 AM
The LinkedIn post from Max carries
(10)
chazzledazzle
07/02/2025 12:14:12 AM
I hope so too. That does make it seem
(3)
Evil Rabbit
07/02/2025 12:11:21 AM
After years of doing this, I feel like
(15)
Newer
Older
Recent Articles
Trump's Tariffs Controversy: Why He Stays Away from Court
Savara Inc. Legal Update: What Investors Need to Know
V.F. Corporation Investors Should Be Aware of Class Action
Engwe Unveils Advanced E-Bikes at Major Milan Event
Trump's Unique Views on Cryptocurrency and His Family's Role
Concluding Highlights of the Financial Street Forum 2025 Events
Stock Market Update: Nasdaq Climbs as Earnings Surprise Investors
Stocks to Keep an Eye on This Monday: Key Updates & Insights
Trump's Stance on Nvidia's Blackwell AI Chip and Its Future
2025 Gold Glove Award Winners Announced: Defensive Excellence
Faraday Future Welcomes Chris Nixon Cox as Strategic Advisor
Tronox Holdings Investors Urged to Take Action Before Deadline
How the Surge in AI Usage is Impacting Our Energy Bills
Cryptocurrency Market Update: Key Insights on BTC, ETH, and More
Aquilius Achieves Record-Breaking Fundraising Success
GFM Services Berhad Earns Leadership Recognition for Innovation
AgiBot Pioneers Reinforcement Learning in Robotics Deployment
Aquilius Secures $1.1 Billion for Asia Pacific Real Estate Fund
AgiBot Unveils Milestone in Reinforcement Learning Robotics
Aquilius Secures Unprecedented $1.1 Billion for Real Estate Growth
Exploring the Renaissance of Baijiu: A Global Affair
Nota AI's KOSDAQ Listing Marks a New Era for AI Innovations
Faraday Future Expands Operations with Strategic Partnerships
Bitget and Fasanara Capital Unite for Enhanced Digital Asset Liquidity
WPP plc Investors Urged to Act Before Class Action Deadline
HUTCHMED Showcases Innovative Cancer Treatments at Recent Event
Benitec Biopharma's Latest Update: Advancing Gene Therapy Research
Benitec Biopharma Updates Phase 1b/2a Study for OPMD
HUTCHMED Advances Innovative Cancer Treatments and Pipeline
Join the Movement: Stand Up Against Fraud with Rosen Law
SAMURAI Paint Unveils Innovative Car Spray Paint Series
FireFly Welcomes New Non-Executive Director with Vast Industry Expertise
Dave Ramsey's Critique of Congressional Incompetence
Critical Insights on Savara Inc. and the Upcoming Class Action
FireFly Metals Welcomes Experienced Director to the Team
Discovering Innovations in Vascular Treatments from The VEINS 2025
Lantheus Holdings Class Action: What Investors Need to Know
Unveiling America's Tech Revolution: Buck Sexton's Insights
Alvotech Faces Challenges in Biologics License Approval Process
Alvotech's Progress on FDA Review for AVT05 Biosimilar
Secure Your Rights: Join the Avantor, Inc. Class Action
Latest Updates on Caribou Biosciences' CAR-T Cell Trials
How Tanka's AI Platform is Shaping the Future of Startups
Caribou Biosciences Announces Upcoming Webcast for CAR-T Data
Kevin O'Leary's Journey: Overcoming Failures to Find Freedom
The Secrets Behind A $6.5 Million Used Clothing Business Success
Important Legal Update for Tronox Investors: Act Now
Class Action Alert: Quantum Corporation Stockholder News
Warren Buffett's Reflective Lessons from Investment Mistakes
Transforming Housekeeping into a Lucrative Career Path